CollPlant Biotechnologies (CLGN) Depreciation & Amortization (CF) (2018 - 2025)

CollPlant Biotechnologies (CLGN) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $216000.0 in Q4 2025.

• Quarterly Depreciation & Amortization (CF) fell 10.74% year-over-year to $216000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $668000.0 (down 11.87% YoY) and the FY2025 annual result came in at $912000.0, down 12.14% from the prior year.
• Depreciation & Amortization (CF) eased to $216000.0 in Q4 2025, from $223000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $294000.0 in Q4 2022 to a low of $173000.0 in Q1 2021.
• A 5-year average of $245105.3 and a median of $255000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 45.81% — and 2024, when it declined 14.79%.
• Tracing CLGN's Depreciation & Amortization (CF) over 5 years: stood at $224000.0 in 2021, then jumped by 31.25% to $294000.0 in 2022, then declined by 3.4% to $284000.0 in 2023, then slipped by 14.79% to $242000.0 in 2024, then fell by 10.74% to $216000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $216000.0 (Q4 2025), $223000.0 (Q3 2025), and $229000.0 (Q2 2025), per Business Quant data.